According to Innoviva's latest financial reports the company's current earnings (TTM) are $0.26 B. In 2022 the company made an earning of $0.28 B a decrease over its 2021 earnings that were of $0.44 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.26 B | -6.37% |
2022 | $0.28 B | -35.56% |
2021 | $0.44 B | 25.7% |
2020 | $0.35 B | 52.11% |
2019 | $0.23 B | 10.77% |
2018 | $0.21 B | 56.59% |
2017 | $0.13 B | 125.53% |
2016 | $59.53 M | -417.35% |
2015 | -$18.76 M | -85% |
2014 | -$0.13 B | -26.74% |
2013 | -$0.18 B | 820.63% |
2012 | -$18.55 M | -83.92% |
2011 | -$0.12 B | 47.27% |
2010 | -$78.33 M | -2.36% |
2009 | -$80.22 M | -8.62% |
2008 | -$87.79 M | -47.92% |
2007 | -$0.17 B | -5.92% |
2006 | -$0.18 B | 19.8% |
2005 | -$0.15 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | -$0.27 B | -197.52% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | -$20.85 M | -107.76% | ๐บ๐ธ USA |